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                                            INTRODUCTION
Ever  since  Koller’s  original  work,  the  popularity  of  local  anaesthetic  has  waxed & 
waned, like that of many other medical developments. There were many positive influences 
after Lofgren synthesized lignocaine in 1943. Bupivacaine is particularly important, since its 
long  duration  of  action  avoids  repeated  injection  with  relatively  little  risk  of  cumulative 
toxicity.
Today  regional  anaesthesia  is  well  established  as  equal  to  general  anaesthesia  in 
effectiveness & patient acceptability.
Regional anaesthesia is the blocking of peripheral nerve conduction in a reversible way 
by using local anaesthetic agents thereby one region of the body is made insensitive to pain and 
is devoid of reflex response to surgical stimuli. In this the CNS is spared, so that the patient is 
conscious, fully awake during the surgical procedure without recognizing pain.
For  surgeries  on  upper  extremities  particularly  in  emergency  surgeries  regional 
anaesthesia has many advantages over general anaesthesia. 
         The frequent use of pneumatic tourniquet33 to provide a bloodless field during surgery 
makes individual nerve blocks impractical.  Brachial plexus block28  is the answer in such a 
situation.  There are different approaches but the ones frequently employed for blocking the 
brachial plexus29 include
a) Supraclavicular approach
b)  Infraclavicular approach
c) Axillary approach
d) Interscalene approach
          Axillary approach30 has the lowest incidence of serious complications and can be 
performed with ease.  But there are limitations associated with axillary approach31,32 like
• It is inadequate for operations on the arm and shoulder.
• It is difficult to block the musculocutaneous nerve predictably with resultant sparing 
of the radial aspect of forearm and dorsum of hand.
• Tourniquet pain is not well tolerated.
• Also abducting the arm by 90 degrees for giving the block may be painful and even 
dangerous in traumatic lesions of the upper extremity.
            The brachial plexus is approached at the level of trunks and the compact arrangement of 
trunks at supraclavicular level gives a high success rate with minimum local anaesthetic drug 
volume and a dense & fast onset of block. Hence the supraclavicular approach is the method of 
choice for blocking the brachial plexus.29
.
     William  Steward  Halsted  first  performed  brachial  plexus  block  in  1885.   In  1911, 
Kulenkampff  and  Hirshel  described  the  first  percutaneous  brachial  plexus  block  by 
supraclavicular and axillary routes respectively.
    Since then several techniques of brachial plexus block have been described with the 
purpose  of  improving  the  efficacy  and  success  rate  and  minimizing  the  risk  and  rate  of 
complications.  Of the various techniques29 the most widely practiced methods are the classical 
technique described by Patrick (1940), Vertical plumb bob approach described by Brown, 1st 
rib  walk  over  technique  described  by  Bonica  and  Moore  and  the  Subclavian  perivascular 
technique described by Winnie and Collins (1964).
      Of the several local anaesthetic drugs used for brachial plexus block, bupivacaine is used 
most frequently in our set up as it has a long duration of action varying from 3 – 8 hours30,33,34.  
      To prolong the duration of analgesia various drugs have been studied as adjuvant to the 
local anaesthetic solution and techniques like the continuous catheter placement in the plexus 
have  evolved.   These  adjuvant  drugs  ideally  are  expected  to  prolong  the  analgesic  effect 
without causing any systemic side effects or prolonging motor blockade.  
Nerve  locators  are  now widely  seen  as  useful  aids  in  nerve  blocks.  Its  use  avoids 
paraesthesia, decreases the chance of nerve injury and gives high success rate. 
         Clonidine  is an α2 agonist has an anti-nociceptive effect on a wide dynamic range of 
neurons and receptors. In animal studies, Clonidine depressed impulse conduction in isolated 
nerve fibre with some preference for C-fibres. Used as the sole analgesic, it produced analgesia 
after  intrathecal,  epidural  and  intra  articular  administration.  Clonidine  can  be  safely 
administered  along the  neuroaxis  and  is  being  used  as  an  adjunct  to  local  anaesthetics  to 
increase the duration of analgesia.  It  produces analgesia by interacting with α2- adrenergic 
receptors.  These receptors are located on superficial laminae of spinal cord and brain stem 
nuclei implicated in pain. So analgesia may be produced at peripheral, spinal and brain steam 
sites. 
          This study is intended to determine the effects of adding Clonidine to Bupivacaine in 
brachial plexus blockade by Nerve locator assisted supraclavicular approach, with regard to the 
onset, intensity and duration of blockade along with its analgesic efficacy.
AIM OF THE STUDY   
  
      The aim of the present study is to evaluate the effect of addition of 100µg of Clonidine 
to  0.375%  Bupivacaine  solution  in  Supraclavicular  brachial  plexus  block  with  regard  to 
following parameters. 
• Onset of blockade
• Duration of blockade 
• Intensity of blockade
• Sedation 
• Quality of analgesia
• Haemodynamic changes &
• Complications if any 
ANATOMY OF BRACHIAL PLEXUS 35-39
     Knowledge  of  the  formation  of  the  brachial  plexus  and  of  its  distribution  is 
absolutely essential for the precise and effective use of brachial plexus analgesia for surgeries 
of  the  upper  limb.   A  thorough  understanding  of  the  vascular,  muscular  and  fascial 
relationships of the plexus throughout its formation and distribution is equally essential in order 
to master the various techniques of brachial plexus analgesia.
     In its course from the intervertebral foramina to the arm, the fibres that constitute the 
plexus are composed consecutively of roots,  trunks, divisions, cords and terminal branches, 
which are formed through a complex process of combining, dividing, recombining and finally 
redividing.
    The brachial plexus is formed by the union of the anterior primary rami of the fifth to 
eighth cervical nerves and first thoracic nerve with occasional contributions from the fourth 
cervical nerve (prefixed) above and second thoracic nerve (postfixed) below.  These nerves 
unite  to form trunks, which lie  in the neck above the clavicle.   Its  roots pass between the 
scalenus anterior and the scalenus medius  which is enclosed by fascia accompanied by the 
subclavian artery and then invaginates the scalene fascia to form a neurovascular bundle.  This 
fascia becomes the axillary sheath in the axilla.
Relations of Brachial Plexus
Anterior relations
     The skin, superficial fascia, platysma, and supraclavicular branches of the superficial 
cervical plexus, the deep fascia and external jugular vein.  The clavicle is in front of the lower 
part and scalenus anterior is in front of the upper part.
Posterior relations
     Scalenus medius and the long thoracic nerve of Bell.
Inferior relations
     Related to the first rib.
Superior relations
     Lies first above and then lateral to the subclavian artery.
Sympathetic contribution to the plexus
     Close to their emergence, the 5th and 6th cervical nerves, each receive a grey ramus from 
the middle cervical sympathetic ganglion.  The 7th and 8th cervical nerves each receive a grey 
ramus from the inferior cervical ganglion.
Roots
      Anterior primary rami of C5,C6,C7, C8 and T1 ( occasionally C4 or T2 ).
Trunks
• Upper trunk – anterior rami of C5 and C6
• Middle trunk – anterior ramus of C7
• Lower trunk – anterior ramus of C8 and T1.
Divisions
     Behind the clavicle each trunk divides into anterior and posterior divisions.
Cords
• Lateral cord – Anterior divisions of upper and middle trunks (C5 – C7)
• Medial cord  - Anterior division of lower trunk (C8 – T1)
• Posterior cord – Posterior divisions of all the three trunks  (C5 – T1)
Branches
 From Roots
• Nerve to serratus anterior C5,C6, C7
• Muscular branches to longus cervices C5,C6,C7,C8.
• Nerve to the three scalene C5,C6,C7,C8.
• Nerve to Rhomboids C5
• A twig to phrenic nerve C5.
From Trunks
• Suprascapular nerve C5 , C6
• Nerve to subclavius C5 , C6
From Cords
• Lateral cord (three):
          Lateral pectoral C5,C6,C7
          Lateral root of the Median C5,C6,C7
          Musculocutaneous C5,C6,C7
• Medial cord ( five ):
               Medial root of median nerve C8, T1
              Medial pectoral C8, T1
               Medial cutaneous N of forearm C8, T1
               Medial cutaneous N of arm C8, T1
               Ulnar C8, T1
• Posterior cord
              Radial C5 – T1
              Axillary C5 – C8
              Thorocodorsal C6 – C8
              Upper and lower subscapular  C5 – C6
Familiarity  with  the  perineural  structures  that  surround  and accompany the  brachial 
plexus as it leaves the vertebral column on its course to the upper arm is as important as the 
knowledge of the formation and distribution of the neural plexus itself.  Palpable muscular and 
vascular landmarks allow accurate location of the plexus percutaneously.  An appreciation of 
the  fascial  relations  is  absolutely  essential  since  this  is  the  basis  for  all  the  perivascular 
techniques.
     After  leaving  the  intervertebral  foramina,  the  anterior  primary  rami  of  the  nerves 
destined to become the brachial plexus travel in the gutter formed by the anterior and posterior 
tubercles of the corresponding transverse processes of the cervical vertebrae.  After leaving the 
transverse process, the roots of the plexus descend in front of the middle scalene muscle, which 
arises  from  the  posterior  tubercles  of  the  transverse  processes  of  the  lower  six  cervical 
vertebrae.  The insertion of this muscle on the first rib is separated from that of the anterior 
scalene muscle by the inferior trunk of the brachial plexus.  The anterior scalene muscle arises 
from the anterior  tubercles of the transverse process of the 3rd – 6th cervical  vertebrae and 
inserts on the scalene tubercle of the first rib, thus separating the subclavian artery from the 
subclavian vein.
      The fascia covering both the scalene muscles is derived from the prevertebral fascia, 
which splits to invest these muscles and then fuses again at their lateral margins to form an 
enclosed  interscalene  space.   Therefore,  as  the  roots  leave  the  transverse  processes,  they 
emerge between two walls of the fascia 
 covering the anterior and middle scalene muscles.  In their descent towards the first rib to form 
the trunks of the plexus, the roots may be considered to be sandwiched between the anterior 
and middle scalene muscles, the fascia of which serves as a sheath of the plexus.  As the trunks 
approach the first rib, they are arranged ( as their designations – superior, middle and inferior 
imply )  one above the other vertically, not one next to the other horizontally as depicted in so 
many texts.
     As the trunks of the plexus cross the first rib, they are joined by the subclavian artery, 
which lies in a plane anterior to the trunks, so that the inferior trunk lies behind the artery in the 
subclavian groove with the middle and superior trunks above the level of the vessel.  At this 
level the artery and trunks are moving laterally, across the ribs and invaginate the scalene fascia 
to form the subclavian perivascular space, which is continuous medially and superiorly with the 
interscalene space and inferiorly and laterally with the axillary perivascular space.
The  important  concept  is  that  there  is  a  continuous  fascial  enclosed  perineural  and 
perivascular  space  extending  from the  cervical  transverse  processes  to  several  centimeters 
beyond  the  axilla;  this  space  has  been  divided  into  an  axillary  perivascular  space  and  an 
interscalene space.  The existence of such a continuous perineural space renders brachial plexus 
block  simple.   The  space  described  may  be  entered  at  any  level,  and  the  volume  of  the 
anaesthetic  injected  at  that  level  would  determine  the  extent  of  anaesthesia.   Thus,  the 
technique to be used in any case should be determined on the basis of the surgical site, the 
required level of anaesthesia, the physical status and habitus of the patient.
      The upper medial aspect of the arm is not anaesthetized by any brachial plexus block 
technique, since this area is innervated by the intercostobrachial nerve T2. This nerve can be 
blocked by subcutaneous infiltration across the upper medial aspect of arm using 3-5ml of local 
anaesthetic solution for surgical anaesthesia  or tourniquet.
     The brachial plexus can be blocked at the level of the roots, trunks, cords or peripheral 
branches.   The  block  at  each  level  has  a  distinct  distribution  of  anaesthesia,  advantages, 
disadvantages, and complications.

CLINICAL   PHARMACOLOGY 42,43,44  
This chapter concerns with the brief review of the clinical pharmacology of drugs used 
in this study. 
BUPIVACAINE  HYDROCHLORIDE
It is an amide local anaesthetic synthesized by B.O. Af. Evenstam in 1957 of  AB  Bofor 
in Sweden.
First came into clinical use in 1963 by Widman & Teliuvo.
Chemisry:
An amino amide local anaesthetic having aromatic moiety (benzene ring), which  offers 
lipophilicity to one end of the molecule. It is linked by an amide to a tertiary amine, which is 
hydrophilic on the other end of the molecule.
IUPAC Name: 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
C18H28N2O
It displays stereoisomerism. Marketed as a racemic mixture containing optically active 
enantiomers R and S. S–enantiomers have been noted to have slightly longer duration of action 
and lower systemic toxicity when compared to   R-type.
Presentation :
As a clear solution of 0.25/0.5%  bupivacaine hydrochloride. The hyperbaric solution 
contains  80mg/ml of glucose.
Physico chemical properties :
Molecular Weight : 288
pKa (25oC) : 8.2
Protein Binding : 96%
Lipid Solubility : 28
% Non ionized form at  pH  7.4  –  17
                                 pH  7.2   – 11
Mechanism of action :
                        Local anaesthetics such as bupivacaine block the generation and the conduction 
of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, 
by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action 
potential. In general, the progression of anaesthesia is related to the diameter, myelination and 
conduction velocity of affected nerve fibers. Clinically, The order of loss of nerve function44 is 
as follows: (1) Autonomic, (2) temperature, (3) pain, (4) proprioception, and (5) motor. In a 
mixed nerve  it  depends  on  the  histological  arrangement  of  the  nerve  fibre.  The  analgesic 
effects of Bupivacaine are thought to be due to its binding to the prostaglandin E2 receptors, 
subtype EP1 (PGE2EP1), which inhibits the production of prostaglandins,  thereby reducing 
fever, inflammation, and hyperalgesia.
Pharmacokinetics:
The absorption of local anaesthetics is related to
The site of injection (Intercostals > Epidural > brachial plexus > subcutaneous)
The dose :   a linear relationship exists  between the total dose and the peak blood 
concentration achieved.
The presence of vasoconstrictors which delay absorption.
The  addition  of  adrenaline  to  bupivacaine  does  not  influence  the  rate  of  systemic 
absorption as
The drug is highly lipid soluble and therefore uptake into fat is rapid.
The drug has a direct  vasoconstrictory effect.
Routes of administration  / Doses:
Bupivacaine may be administered topically by infiltration, intrathecally or epidurally. 
The therapeutic dose of bupivacaine is 2-3 mg / kg (with or without adrenaline).
The drug acts within 10 to 20 minutes and has an average duration of action of 5-6 
hours.
Concentration Used :
Infiltration – 0.25%
Peripheral nerve block - 0.25  - 0.5%
Epidural Anaesthesia - 0.25% - 0.5%
Spinal Anaesthesia - 0.5% Heavy
Epidural Analgesia - 0.0625% - 0.25%
Pharmacokinetics :
The possible pathways for metabolism of bupivacaine include aromatic hydroxylation, 
N-dealkylation,  amide  hydrolysis  and  conjugation.  Only  the  N-  dealkylated  metabolite  N-
desbutyl Bupivacaine has been measured in the blood or urine.
Alpha 1 acid glycoprotein is the most important protein binding site of Bupivacaine. 5% 
of the dose is excreted in the urine as pipcolloxylidine. 16% is excreted unchanged. Clearance 
is 0.47 l/min and the elimination half life is about 210 minutes.
Systemic toxicity :
Cardiovasular system
       Bupivacaine  is  markedly  cardiotoxic.  It  binds  specifically  to  the  myocardial 
proteins.  In  toxic  concentrations  the  drug  decreases  the  peripheral  vascular  resistance  and 
myocardial  contractility  producing  hypotension  and  possible  cardiovascular  collapse. 
Cardiotoxic plasma concentration of bupivacaine is    8-10 μg/ml.
Central nervous system :
           The principal effect of bupivacaine is reversible neural blockade. This leads to a 
characteristically biphasic effect in the central nervous system. During accidental over dosage 
or direct vascular injections the clinical signs are numbness of tongue, lightheadedness, visual 
and  auditory  disturbances,  muscular   twitching  and  tremors.  The  signs  may  progress  to 
generalized convulsion of the tonic clonic nature. When plasma levels continue to rise, CNS 
excitation is rapidly superseded by depression.(drowsiness, disorientation and coma)
    The typical plasma concentration of bupivacaine associated with seizure is   4.5 to 5.5 
μg / ml.
Allergic reactions :
Allergic reactions to the amide type local anaesthetics are extremely rare. 
CLONIDINE HYDROCHLORIDE
        Clonidine  an  α 2 agonist synthesized in 1960 was originally developed for intranasal 
administration as a nasal decongestant. Due to its systemic effects (sedation & hypotension) its 
use as a decongestant has been abandoned.
Chemistry :
Clonidine is an imidazole compound.  Molecular weight :  266.56
IUPAC Name : N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine
Structure:
            
Presentation: 
Oral form - 100, 150 μg tablets  ,  Injection  150 μg/ml - clear colourless solution as 
Clonidine hydrochloride.
Pharmocokinetics :
Oral bioavailability - 100%
Plasma protein binding - 30-40%
Peak Plasma concentration - Reached in  60-90 minutes
Maximal hypotensive effects - 1-3 hours after an oral dose
Elimination half life - 6 – 24 hours.
Approximately 50% of the  drug is  metabolized in  the  liver  to inactive  metabolite  – 
P.hydroxyl-clonidine, while the rest is excreted unchanged by the kidney. Approximately 20% 
of the total amount is excreted with the faeces. 
Mechanism of action :
Activation  of  α2  receptors  in  lower  brain  stem  ;  these  are  noradrenergic  imidazoline 
preferring binding sites but they do not bind catecholamines.
Decreases discharge in sympathetic preganglionic fibres in sphlanchnic nerves as well as in 
postganglionic fibres of cardiac nerves.
Stimulates parasympathetic outflow.
Suppression of release of noradrenaline from peripheral nerve endings.
Decreases plasma concentration of noradrenaline and reduces its excretion in urine.
Systemic effects of Clonidine
 System                           Site of Action                                 Effects          
                     
Cardiovascular               Brainstem; Spinal cord           Decreased BP. HR
                                       Peripheral vasculature             Increased BP. SVR
                                       Heart                                       Slowed conduction
  
Central Nervous            Locus coeruleus         Sedation, anaesthesia 
System
Pain transmission          Peripheral nerve endings         Reduced sensitivity 
                                      Brainstem                                 Analgesia 
Respiration                    Brainstem                                Reduced respiratory drive
Endocraine                    Hypothalamus, Pituitary          Decreased ACTH, LH
   
                                                                                       FSH, AVP, Increased GH
                                       Pancreatic islets                      Decreased Insulin
                                       Spinal cord , periphery           Decreased 
                                                                                       Catecholamines  
Clonidine prevents adrenaline induced arrhythmias during halothane anaesthesia. 
It decreases cerebral blood flow, protecting the brain from abrupt increase in intracranial 
tension.
Clonidine causes hyposalivation, prevents intestinal ion and water secretion in the large 
bowel.
It induces diuresis
It induces platelet aggregation. 
Clinical  Uses :
*  Premedication
As a premedicant 90-120 minutes prior to induction, produces good sedation, maintains 
cardiovascular stability intraoperatively without respiratory depression.
It decreases intraocular pressure both before and during surgery.
            * Intraoperative and Postoperative uses :
Intrathecal  clonidine  (150μg)  as  adjuvant  with  local  anaesthetics  prolongs  spinal 
anaesthesia.  
Clonidine in extradural  route is used
-   to produce postop analgesia
- for the relief of neuropathic pain and as a therapeautic adjunct in the management of 
refractory reflex sympathetic dystrophy.
- For cancer pain management
Clonidine may diminish myocardial ischemia intra and post operatively after a single 
dose providing an important indication in high risk patient.
Clonidine  as  adjuvant  to  local  anaesthetics  prolongs  anaesthesia  &  analgesia  in 
peripheral nerve blocks.
Considerations for use of clonidine in Anaesthesia:
 Advantages :-
Preservation of haemodynamic stability.(Prevent wide swings in HR& BP).
Induced hypotension.
Limits the use of potentially toxic anaesthetic / adjuvant agents.
Preservation of renal function in presence of insult.
Limits the increase in ICP/IOP.
Decrease of narcotic induced muscle rigidity.
Bronchodilation
Disadvantages :
Transient Hypertension. (Parenteral bolus administration)
          I.V. infusion causes acute rise in B.P. because of activation of post Synaptic α2 
receptors  in  vascular  smooth  muscle  followed  by  a  more  prolonged  hypotension  due  to 
decreased central outflow of impulses in the sympathetic nervous system.
Hypotension
Bradycardia
Sedation
Dry mouth
Reversal :
Clinical effects of Clonidine can be reversed by Atipamezole
PHARMACOKINETICS OF LOCAL ANAESTHETICS IN 
BRACHIAL PLEXUS BLOCKADE40
    When a local anaesthetic is injected around a nerve trunk, it will soak the trunk in an 
advancing front.  Transmission in fibers situated in the periphery of the trunk (mantle fibres) 
will be first blocked and those in the centre of the trunk (core fibres) last.  Further, transmission 
in peripherally placed fibres will be blocked over a longer length of time compared to central 
fibres.   Thus  analgesia  will  appear  first  and  last  longest  in  the  territory  supplied  by  the 
peripheral fibres.  If the pool of local anesthetics is small or if the injection was not accurate or 
too dilute, the fibres in the centre of the trunk will escape blockade.
Theory of Winnie
     The  trunks  are  arranged  so  that  the  central  fibres  are  the  longest  supplying  the 
extremities of the limb while shorter fibres are arranged more peripherally  as their  area of 
supply is more proximal.  Winnie groups the fibres into two: the peripheral mantle fibres which 
contain the motor fibres and core fibres which are 
mainly  inner  sensory.   Peripheral  motor  fibres  supply  the  muscles  of  the  forearm and the 
central fibres carry sensation from the hand. 
 Thus the onset of block in the limb is as follows:
• Loss of motor power to the shoulder and upper arm
• Loss of sensation on the upper arm
• Loss of motor power of the forearm
• Loss of sensation to the hand.
           So the spread of block is from proximal to distal.
BASICS   OF   NERVE   LOCATOR  45,46  
    Perivascular technique and elicitation of paraethesia had been the classical methods 
for locating nerves in peripheral nerve blocks. Peripheral nerve locator technology is a newer 
one, utilizing objective end points for effective nerve localization.
 Peripheral nerve locator is used to elicit Evoked Motor Response(EMR). They are used 
to  assess  functioning  of  Neuromuscular(NM)  junction.  The  names  Peripheral  nerve 
locator(PNL),  and  Peripheral  nerve  stimulator(PNS)  mean  the  same.  When  high  intensity 
current is used to assess NM junction function through cutaneous electrodes it is called as PNS. 
When low intensity current is used to locate the nerve it is called peripheral nerve locator.
History :
Perthes  in  1912  and  Pearson  in1955 demonstrated  that  a  peripheral  nerve  could  be 
identified by electro stimulation21,22,23, but it was the work of Greenblatt and Denson24 in 1962 
that introduced the nerve stimulator into anaesthesiology clinical practice. With a resurgence of 
interest in regional anaethesia and demand for more accurate nerve localization before injection 
of local anaesthetics, the field of peripheral nerve locators has grown into a larger extent.
Physiological  Basis  of  PNL  Technology :
The ability of a nerve locator to evoke a motor response depends on
i) intensity of current
ii) duration of current
iii) polarity of stimulating current used   &
iv) needle nerve  distance .
Assuming a square pulse of the current is used to stimulate the nerve the total charge 
applied is the product of intensity of current and duration of the pulse.
Reobase  and  Chronaxie :
Reobase is the minimal current required to stimulate the nerve with a long pulse width.
Chronaxie is the duration of the stimulus required to stimulate at twice the reobase.
       I =  Ir (1+c/t)
Where I   - current required, C   - Chronaxie,
Ir  - reobase, t    - duration of stimulus.
Chronaxie is useful when comparing different nerves or nerve fibre types. The larger 
fibres are more readily stimulated than the smaller fibres. It is possible to stimulate the larger 
Aα motor fibre without stimulating the smaller Aδ or          C -fibres responsible for pain.
Chronaxies of Peripheral Nerves
                          *     A-α           50 -100 μ Seconds
                          *    A-δ             170  μ Seconds
                          *   C-Fibres       400  μ Seconds
Principles of Peripheral nerve stimulation :
i) Preferential cathodal stimulation:
Significantly  less  current  is  needed  to  obtain  a  response  to  nerve  stimulation  when 
cathode is adjacent to the nerve, rather than the anode.
ii) Variation of stimulus intensity with varying needle nerve distance.
Stimulation intensity  will  be variable as determined by coulomb’s law. A very high 
stimulus current is required to stimulate the nerve when the needle tip is far away from the 
nerve. 
Components of peripheral nerve locators :
Oscillator
Display
Constant current generator
Controls.
Characteristics  of  an  ideal  PNL
1) Constant current output:-
The constant current designs of the locator allows for an automatic compensation for 
changes in tissue or connection impedance during nerve stimulation assuring accurate delivery 
of the specified current.
2) Options for different pulse width:-
Shorter pulse width corresponds to the chronaxie of motor fibres in a mixed peripheral 
nerve. Wider pulse width ( >100μ sec) is useful for stimulating a sensory nerve or a nerve with 
compromised conduction  i.e. Diabetic neuropathy.
3) A wide range of current output - 0.01 to 5.0 mA :-
A  higher  current  output  is  needed  for  patients  with  neuropathy  and  sensory  nerve 
stimulation. 
4) Digital display of the delivered current.
5) Variable current output dial.
6) Clearly identifiable polarity 
7) Disconnect indicator
- Shows circuit connection status 
8) Battery indicator
9) Stimulating frequency:-
If the stimulating frequency is higher, it allows faster manipulation of the needle.
Clinical points to be noted while using PNL:
An effective use of PNL technology mandates knowledge of anatomy with respect to
a) Optimal needle insertion site to achieve needle tip – target nerve contact.
b) Muscle innervation scheme of the targeted nerve to identify desired evoked motor 
response(EMR).
c) Ability  to  differentiate  desired  EMR  from  the  alternate  EMR  elicited  by  the 
stimulation of adjacent muscle and collateral nerves.
d) The  relationships  of  adjacent  neuromuscular  structures  generating  those  alternate 
EMR to the targeted nerve.
e) The highest rate of success is attained when a brisk EMR occur between 0.2-0.4mA. 
An  EMR at currents  higher  than 0.5mA may result  in  failed block because  the 
needle tip is too far from the nerve. A brisk EMR at stimulating current lower than 
0.1mA may risk nerve damage  because of the possibility of an intraneural injection.
Peripheral Nerve Locator Settings :
1) Mixed nerve (most PNB)
          Current    1 mA
          Current duration(Pulse with)    0.1ms
           Frequency    1-2 HZ
2) Sensory nerve  (eg. Lateral cutaneous and saphenous nerve)
         Current     2-5 mA
         Current duration  1ms
          Frequency  1 Hz
3) Diabetic neuropathy (PNB)
          Current  2 mA
          Current duration  0.3 ms
          Frequency  1-2 Hz
APPROPRIATE  EVOKED  MOTOR  RESPONSE  FOR  EACH PNB 
PNB Technique Optimal EMR
Interscalene
Flexor – Deltoid, Biceps, Pectoralis major.
Extensor  –  Triceps,  Brachioradialis,  Wrist 
Extensors.
(EMR of > 2 muscles)
Deep Cervical Plexus Rhomboids, Shoulder girdle.
Infraclavicular Muscles of wrist and hand.
Radial – Extension of wrist / fingers.
Median – Flexion of wrist / fingers.
Ulnar – Adduction of thumb/4th & 5th finger flexion.
Femoral Quadriceps – Patellar snap
Sciatic Inversion, Plantar flexion
REVIEW OF LITERATURE
* In 1980 winnie & collins1,2 described the subclavian perivascular technique.
Nerve locator :
*  In 1985 smith DC et al8 described an inexpensive, portable nerve stimulator which is 
used to enhance the ease and effectiveness of peripheral nerve blockade.
*  Zaharai DT et al9 described the use of a nerve stimulator which allows accurate 
nerve blocks without causing paraesthesiae and decreasing the possibility of nerve injury.
*  Bashein G et al10 and Ford DJ et al12 in their independent studies concluded that, in 
nerve stimulator assisted nerve blocks, insulated needles more precisely located the peripheral 
nerves than uninsulated needles.  
*  In 1980 Yasuda I et al11 described the use of nerve stimulator with insulated needle 
in supraclavicular brachial plexus block. They identified the plexus at a mean depth of 27mm 
below the skin and the block was successful in 98% of patients when the stimulation was felt in 
the index, middle or ring finger.
Clonidine in Spinal Block:
*  Racle JP et al4 conducted a study to compare the effects of Clonidine, epinephrine on 
duration of bupivacaine spinal anaesthesia in 60 orthopaedic hip surgeries. They concluded that 
significant prolongation of motor block was associated with addition of  0.15 mg of Clonidine 
with 15mg of bupivacaine.
*  Acalovischi   et  al5 studied the effects  of intrathecally   administered a adrenaline, 
clonidine on the duration and quality of Meperidine spinal block in 45 orthopedic surgeries. 
They concluded that co-administration of epinephrine or clonidine with meperidine enhances 
the duration and degree of spinal anaesthesia and that adding clonidine prolongs the duration of 
postoperative analgesia.
Clonidine in Epidural Block :
* In  1994  Lee JJ et  al6 have assessed the  clinical  value  of  combning 2 μg /kg of 
clonidine with 0.25% Bupivacaine 1 ml /kg for caudal analgesia in 46 children aged 1-10 years 
undergoing  elective  orthopaedic  surgery.  They  observed  longer  duration  of  sedation  in 
clonidine group partly from the longer duration of analgesia provided by clonidine and partly 
from  the  sedative  effect  of  clonidine.  They  concluded  that  when  added  to  Bupivacaine, 
clonidine improves the efficacy of caudal analgesia in children.
*  Dr.Lt.Col.Upadhyay K.K et al7 demonstrated that the addition of chonidine in the 
doses of 1μg/kg to 0.75 ml/kg of 0.25% bupivacaine for caudal blockade significantly prolongs 
the duration of analgesia without any additional risk for use in paediatric patients.
Clonidine in peripheral nerve blocks :
*  Eledjam et al13 evaluated the effects of clonidine hydrochroride 150 μg, epinephrine 
200 μg, with 40-50ml of 0.25% bupivacaine, injected into brachial plexus sheath using the 
supraclavicular technique in 60 patients who underwent upper limb surgeries. They concluded 
that  the  injection  of  clonidine  into  brachial  plexus  sheath  is  an  attractive  alternative  to 
epinephrine to prolong the duration of analgesia following upper limb surgery.
* In 2004 Hutschala D et al14 conducted a study to determine whether Clonidine added 
to Bupivacaine enhances and prolongs the analgesia after brachial plexus block via a local 
mechanism.  They  concluded  that  admixture  of  clonidine  to  bupivacaine  plus  epinephrine 
prolongs and enhances brachial plexus blockade.. Lower plasma concentration of clonidine for 
block treatment strongly suggests a local effect.
*  El saied et al15 conducted a study to evaluate the effect of adding Clonidine 150 μg to 
40 ml of 0.75% Ropivacaine for axillary brachial plexus blockade, on the onset and duration of 
sensory , motor block and duration of analgesia in 50 patients. They concluded that addition of 
150 μg of clonidine to ropivacaine for brachial plexus blockade, prolongs motor and sensory 
block and analgesia, without an increased incidence of side effects.
* Singelyn FJ  et al16 conducted a study to evaluate the effect of 150 μg clonidine added 
to 40 ml of  1% mepivacaine on the duration of anaesthesia and analgesia after axillary blachial 
plexus block in 30 patients scheduled for elective hand surgery. They concluded that 150 μg 
clonidine added to mepivacaine for brachial plexus block prolongs the duration of anaesthesia 
& analgesia and this effect of clonidine is local rather than systemic.
Dose range:
                 *  In 1997  Bernard  et al41  studied about the dose-range effects of Clonidine 
added to local anaesthetics for Brachial Plexus Block. They concluded that small dose of 
clonidine enhances the quality of the peripheral blocks from local anesthetics  and limits the 
alpha2 -agonist side effects to the sedation. The best dose to use clinically is between 30  μg 
and 90  μg.
Mechanism  of  Action
*   DM  Gumann  et  al19  examined  local  anaesthetic  effects  of  clonidine  and  its 
interaction with lidocaine with regard to tonic inhibition of the C-fiber action potential on the 
isolated,  desheathed  rabbit  vagus  nerve  by  the  sucrose  gap  method.  They  concluded  that 
clonidine enhances the effects of lidocaine on          C-Fiber action potential.
*   Kroin  JS  et  al17 evaluated  the  mechanism by  which  clonidine  potentiates  local 
anaesthetic  action  in  male  Sprague  –  Dawley  rats.  Their  study  findings  indicated  that 
prolongation of duration of in vivo lidocaine nerve blockade by clonidine is not mediated by an 
α-adrenergic mechanism, but likely involves the hyperpolarization activated cation current (Ih).
           *  Nakamura et al20 Concluded that clonidine in addition to its central analgesic action, 
can  induce  peripheral  antinociception  by  an  α2  adrenoceptor  mediated  local  release  of 
enkephalin like substances.
*   Kopacz et al18 conducted a study to evaluate the effect of Clonidine on lignocaine 
clearance  in  vivo  with  microdialysis  probes.  They  found  that  clonidine  prolongs  local 
anesthetic block party by a pharmacokinetic mechanism.
MATERIALS AND METHODOLOGY
Forty adult patients of both sexes in the age group of 20-60 years belonging to ASA I/II 
category and their weight ranging between 50-70 kgs posted for various types of upper limb 
surgeries at the Department of plastic surgery, Institute of Research and rehabilitation of Hand, 
Government Stanley Hospital, formed the study group.
This  study  was  designed  as  a  prospective  randomized  comparative  study.  After 
receiving the institutional ethical committee approval and informed consent, the patients were 
randomly allocated into two groups. Supraclavicular brachial plexus block was performed via 
peripheral nerve locator assisted subclavian perivascular technique.
Groups:
1. Group – B (Bupivacaine alone) – 20 patients received 30 ml of 0.375% Bupivacaine 
with 2 ml of  0.9%  sodium chloride solution.
2. Group  –  BC  (Bupivacaine  +  Clonidine)  –  20  patients  received  30  ml  of  0.375% 
Bupivacaine with Clonidine hydrochloride  100 μg (1 ml of 150μg diluted with 2ml 
0.9% Nacl solution. From that 2ml used for study.  ). 
Inclusion Criteria:
ASA PS I & II
Age group 20-60 years
Weight 50 – 70 kilograms
Surgeries on forearm and hand
Exclusion Criteria 
Patient refusal
Local infection at needle insertion site.
Coagulopathy 
Patient on anticoagulants. 
Pneumothorax or previous pneumonectomy on the opposite side.
       All patients were  preoperatively evaluated for any systemic diseases  and investigations 
done prior to assessment. Procedure was explained in detail and written consent obtained.
The  procedure  was  carried  out  in  the  theatre,  where  facilities  for  resuscitation  was 
available.
Equipments:
Sterile tray
Sterile towel
Sterile swabs
Sponge holding forceps
Povidone iodine solution
20ml syringe.
2ml syringe with 24 G needle
BRAUN- Stimuplex DIG – Nerve locator
Disposable Braun – Stimuplex (insulated)  needle A50 (22G x2”)
Drugs
0.5% Bupivacaine vial
Distilled water 2 x10 ml vials
Clonidine Hydrochloride ampoule -150 μg/ml
2% lignocaine vial
Intraoperative  and postoperative monitor  ing parameters :  
Heart rate.
O2 Saturation.
Non invasive Blood Pressure
Electro Cardio Graph.
  Initially the preprocedure parameters were recorded i.e., Heart rate, Systolic BP, 
Diastolic BP, Mean BP SPO2& ECG. These were taken as baseline values before giving the 
block.  Then block was performed.  All  through the study these  parameters  were  monitored 
continuously except the NIBP which was recorded intermittently. Postoperatively they were 
monitored for 24 hours.
Patients were observed vigilantly for the development of various complication.
Subclavian Perivascular Technique:
Intravenous line was started for all the patients with 18G (green) intravenous Canula after 
connecting monitors to the patient.
The patient was positioned on the table and proper illumination was done at the site of 
block.
For  Continuous  neurological  evaluation  no  sedative  drugs  were  administered  pre-
operatively.
Position:
• Patient placed in supine position with head turned to the side opposite to the side that is 
to be injected.
• The arms are at the patient’s side with the hands pointing towards the knee.
• The  arm on  the  side  to  be  injected  may  be  pulled  to  depress  the  clavicle  and  the 
shoulder.
• A rolled towel is placed lengthwise between the shoulders along the spine to give the 
best exposure to the area.
Procedure :
            Initially the Nerve locator is set to deliver 0.9 mA current at 2 HZ frequency and 
100 μ sec pulse width & its functional status assessed. Positive pole of the cable is connected to 
the patient’s arm on the side of block. Negative pole of the cable is connected to stimulating 
block  needle.  Injecting  syringe with  local  anaesthetic  solution  is  connected with  extension 
catheter of the block needle.
             In this  procedure the desirable evoked motor response (EMR) with needle 
stimulation is elbow flexion or finger flexion & extension of the hand on block side. Once the 
evoked motor response is obtained, the set current is decreased gradually to  0.2 – 0.4 mA. Our 
target is obtaining an EMR               at    0.2 – 0.4 mA.
Steps 
           The area should  be aseptically prepared and draped.
• The anaesthesiologist stands at the head end of the table.
• The  patient  is  asked  to  lift  the  head  slightly  to  bring  the  clavicular  head  of  the 
sternomastoid muscle into prominence.
• The index finger is placed lateral to the muscle and the patient is said to relax.  Roll the 
index finger  laterally  across the belly  of the muscle until  the interscalene groove is 
palpated.
• The finger is then moved inferiorly down the groove until the pulse of the subclavian 
artery is palpated between the scalene muscles.
• After aseptic preparation, a skin wheal is raised at this point with 2ml of 2% lignocaine 
with a 24G needle about 2 - 3 cms above the midpoint of the clavicle.
• The  pulsation  of  the  subclavian  artery  against  the  palpating  finger   is  a  guide  to 
supraclavicular block.
• The needle enters at the level of C7 in the interscalene groove.
             The stimulating block needle is inserted just above the palpating finger and 
advanced in a direction, which is directly caudal running parallel to the sagittal axis. The needle 
should be held between the thumb and index finger, so the hub lies against the skin of the neck 
during advancement. The needle is advanced behind the palpating finger until an evoked motor 
response of elbow or hand muscle is obtained at 0.2 – 0.4 mA.Once the desirable evoked motor 
response of the elbow or hand is obtained at 0.2 – 0.4 mA the needle is stabilized and 2-3ml of 
local anaesthetic is injected. If the needle is in the perivascular space, the volume of local 
anaesthetic will produce a “pressure paraesthesia”. The rest of the local anaesthetic should then 
be injected in small increments with frequent aspiration to prevent an intravascular injection.
If the needle penetrates the artery, it simply indicates that it is too far anterior.
           *  The intercostobrachial and medial cutaneous nerves are blocked separately at the 
axilla anterior to the axillary artery by subcutaneous infiltration of local anaesthetic to ensure 
complete anaesthesia of the upper extremity.
           *   The needle should not be advanced beyond 2.5 cm to avoid the risk of 
complications. (cervical cord injury, pneumothorax, carotid artery puncture).
           *   A cough by the patient is a warning that the pleura is being irritated by the needle.
     After injecting the local anaesthetic, the block is tested for both sensory ( using  pin 
prick) and motor (using muscle power) and is compared with the same stimulation or power in 
the contralateral arm.  Motor block was evaluated by thumb abduction (Radial nerve), thumb 
adduction  (Ulnar  nerve),  thumb opposition  (  Median  nerve  )  and  flexion  of  the  elbow in 
supination and pronation of the forearm ( musculocutaneous ).
     The Hollmens scale is used in the study for assessing both sensory and motor blockade.
Hollmen’s scale
Sensory blockade(Grade)
1. 0 – Normal sensation of pin prick.
2. + - Pin prick felt as sharp pointed but weaker compared with the same area in other 
extremity.
3. ++ - Pin prick felt as touch with blunt object.
4. +++ - No perception of pin prick.
         Onset of blockade means minimum grade 2 and complete blockade means minimum 
grade 3.
Motor blockade(Grade)
1. 0 – Normal muscle function
2. + - Slight depression in muscle function as compared with pre anaesthetic power. 
3. ++ - Very weak muscular action persisting in muscle.
4. +++ - Complete block with absent muscular function.
          Onset of blockade means minimum grade 2 and complete blockade means minimum 
grade 3.
Nerves studied in the block
Sensory
     Lateral cutaneous nerve of arm
     Medial cutaneous nerve of arm
     Medial cutaneous nerve of forearm
     Posterior cutaneous nerve of forearm
     Lateral cutaneous nerve of forearm
     Median nerve
     Ulnar nerve 
     Radial nerve
Motor
     Median nerve
     Ulnar nerve
     Radial nerve
     Musculocutaneous nerve  
     Evaluation was carried for every minute after completion of the injection and the time 
of onset was noted for both sensory and motor blockade.
     Onset of blockade,  both sensory and motor is  defined as a minimum of grade 2 in 
Hollmen’s scale.
     Blockade was considered complete when sensory and motor scores were at least grade 3 
in Hollmen’s scale.  Only patients with complete sensory block were included in the study.
     Once block was complete, surgery was allowed to proceed.
     Duration of sensory blockade was considered as the time interval between the onset of 
sensory blockade  and the onset  of  paraesthesia (during recovery) while duration of  motor 
block was defined as the time interval between the onset of motor blockade and the recovery of 
motor block.
     Sedation was assessed using the  sedation score described by  Culebras et al.51 where 
sedation was graded on a scale of 1 to 5 as follows:
1. awake and alert
2. sedated, responding to verbal stimulus
3. sedated, responding to mild physical stimulus
4. sedated, responding to moderate or severe physical stimulus
5. not arousable.
Monitoring :
                                Monitoring during  anaesthesia focuses on systemic  effects of Clonidine,  
local anaesthetic toxicity from excessive tissue absorption (usually 40 – 60 min), ventilation , 
oxygenation and the consequences of surgical stress such as tourniquet pain or blood loss.
     Preprocedure parameters i.e., Heart rate, Systolic BP, Diastolic BP, Mean BP 
SPO2& ECG were recorded before  giving block. These were taken as baseline values. All 
through the procedure these parameters were monitored continuously except the NIBP which 
was recorded intermittently. Postoperatively they were monitored for 24 hours. 
As  systemic  absorption  of  clonidine  produces  maximum  haemodynamic  effects 
within 2 hours48, these parameters were recorded over the period of 2hours & compared 
with the baseline values.
               Onset, completion of blockade, duration of blockade was assessed as described 
earlier.
                  Pain was assessed using a numerical rating pain score scale  where 0 
represents  no  pain and 10  means the worst possible pain. (VAS scale – Annexure. 4a )  
Statistics & Analysis:
Sample size of 20 per group was adequate for the present study.
 Data like age, weight, onset, completion & duration of blockade were analyzed using 
students independent  t – test.
Data like intensity of blockade, sedation score were analyzed with   chi-square  test.
Data were expressed as Mean ± SD.  P value < 0.05 was taken as statistically significant.
  Mean values of haemodynamic parameters (Heart rate, systolic BP, diastolic BP, mean 
arterial pressure) over the period of 2 hours (at 10 minutes interval) after giving the block were 
compared with the base line values. Any deviation of more than 30% from the base line values 
were taken  as  haemodynamic instability25,26. 
OBSERVATIONS
DEMOGRAPHIC   PROFILE
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                   The  mean  age  in B  group was 33.35 years + 8.60 SD and in the BC group it was 
34.55 years +  11.56 SD. ( t = 0.37 , p = 0.712 )
                    The mean weight in B group was 58.40 kgs +6.15 SD and  in the 
BC group it was 57.30 kgs  +  4.75 SD. ( t = 0.63, p = 0.530)
                    Sex distribution in each group: 11 males and 9 females.
                    Thus the demographic profile was comparable between the two groups.  ( p value 
= NS ).
                    The mean duration of surgery was comparable between the two groups: 91 + 
16.03 mins in Group B and 94 +12.83 mins in Group BC.( t =0.65, p=0.517)
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The mean time of onset of motor block in 
        Group B         :   6.40 + 1.14 mins 
        Group BC      :   4.25 + 0.72 mins
      The onset of motor blockade was statistically significant in BC group.       (  t = 7.13, p 
<  0.05 ).  
     The onset time of sensory block in 
       Group  B        :   12.00 + 1.97 mins
       Group   BC    :   8.40  + 0.82 mins
        The onset of sensory blockade was statistically significant in BC group.     ( t = 7.53, p 
< 0.001 ).  Motor blockade occurred earlier than sensory blockade in both the groups ( p < 
0.05 ).
COMPLETE  BLOCKADE  (p<0.05)
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   The mean time for complete motor block was 
Group B   :  18.75 +  2.71 mins
Group  BC    :  15.40 + 2.04 mins
         The time for complete motor block was statistically significant in BC group.       (  t = 
4.42, p <  0.05 ).  
     The mean time for complete sensory block was
Group B        :  21.85 + 2.37 mins
Group  BC    :  18.20 + 2.14 mins
              The time for complete sensory  block was statistically significant in BC group.  (  t = 
5.11, p <  0.05 ).  
DURATION  OF  BLOCKADE  (p<0.05)
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        The mean total duration of motor blockade was 
Group B   :  299.00 +  23.32 mins
Group BC :  396.30 +  14.92 mins
         The mean total duration of motor blockade was  statistically significant.   (  t = 15.72, 
p <  0.05 ).  
     The mean total duration of sensory blockade was 
Group B         :  328.95 +  34.13 mins 
Group BC      :  466.75 + 13.91 mins
     The mean total duration of sensory blockade was statistically significant     
(  t = 16.72, p <  0.05 ).   
INTENSITY OF BLOCKADE
Grading Group B Group BC
MOTOR
4 12 (60 %) 15 (75 %)
3 5  (25 %) 4  (20 %)
2 2  (10 %) 0
1 0 1(5%)
SENSORY
4 15 (75 %) 16 (80 %)
3 5  (25 %) 4  (20 %)
2 0 0
1 0 0
Intensity of Motor blockade
     Group B  -  60% patients had grade 4 motor block while 25% had grade 3 and 10 % 
patients had grade 2 motor block.
     Group BC  -  75% patients had grade 4 motor block while 20% patients had grade 3 
block and 5%had grade 1 motor block. 
     This was not statistically significant.  ( X 2 = 3.73, p = 0.29)
Intensity of Sensory blockade
     Group B  -   75% patients had grade 4 sensory block and 25% patients had grade 3 
sensory block.
     Group BC -  80% patients had grade 4 sensory block and 20% patients had grade 3 
sensory block.
      This was not statistically significant.  (X 2 = 0.143, p = 0.704)
SEDATION
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     Sedation scores differed between the two groups during the intraoperative period (at 30 
min). 
Group B    :  None of the patients was sedated i.e. all were awake and alert
 Group BC :  50% patients were sedated and required mild physical stimulus to awaken, 20% 
patients sedated and required verbal stimulus to awaken and 30% not sedated..
     No patient in BC group required assistance for airway maintenance due to sedation. 
     Sedation score achieved during the intraoperative period was statistically significant ( 
χ2=21.53, P<0.001). Sedation scores did not differ between the groups during the postoperative 
period. 
VAS  SCORES
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             Postoperative pain scores were recorded according to Visual Analog  Scale 
( VAS 0 -10, Annexure 4a ) at 6, 12 and 24 hours.  Group BC    patients recorded a lower mean 
VAS score than their counterparts.  Likewise the rescue analgesic requirement (Inj. Diclofenac 
sodium 3ml IM ) was lower in BC group ( 4 patients ) compared to group B (13  patients). 
Both were statistically   significant  ( p < 0.05 ). 
Haemodynamic Parameters:
      The baseline & first 2 hours haemodynamic parameters observed during the  study 
period for both the groups were tabulated as shown in the annexure (2b, 2c,  3b&3c).From 
these, mean value over the period of 2hrs48, mean baseline value, deviation from the baseline (+ 
indicates increase, - indicates decrease) values were derived.
Heart rate  significantly decreased during the intraoperative period when compared to 
baseline values in clonidine group. Diastolic BP, systolic BP, mean arterial pressure were lower 
in clonidine group than control group but not significant.
Parameters
Group-B Group-BC
Mean 
over 2hr
Base
Line
Deviation
From 
baseline
Mean 
over
2hr
Base
Line
Deviation 
From 
baseline
Heart Rate
bpm
71.01
(± 2.27)
78.10
(± 9.65)
-7.03
(± 8.54)
65.00
(± 2.29)
80.00
(± 7.71)
-15.00
(± 7.22)
Systolic BP
mmHg
118.8
(± 4.06)
122.30
(± 9.10)
-3.5
(± 6.19)
113.74
(± 2.84)
119.05
(± 7.33)
-5.31
(± 6.80)
Diastolic BP
mmHg
77.48
(± 2.68)
77.90
(± 5.75)
-0.42
(± 4.90)
75.03
(± 2.20)
79.75
(± 6.21)
-4.72
(± 4.97)
Mean Arterial
Pressure    mmHg
91.25
(± 2.88)
92.50
(±6.43)
-1.25
(± 4.78)
87.9
(± 2.47)
92.85
(± 6.13)
-4.95
(± 4.84)
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No haemodynamic instability ( deviation > 30%) occured in both group during the study 
period.
COMPLICATIONS
          There was one incidence of arterial puncture without formation of hematoma in 
group-B.   Needle  was  again  repositioned,  aspirated  and  drug  administered.   Block  was 
successful.  There was no other incidence of
•  Pneumothorax 
• Neurological deficit
• Phrenic nerve palsy
• Horner’s syndrome 
• Excess sedation 
• LA toxicity
          In one patient (in Clonidine group) heart rate went below 50 during intraoperative period 
and treated with Inj.Atropine 0.6 mg i.v.
        Blood pressure, oxygen saturation and respiration were monitored and were stable.  
DISCUSSION
     Brachial  plexus  blockade  offers  an  excellent  alternative  technique  to  general 
anaesthesia in anaesthetising the upper limb for surgical procedures. Various approaches for 
successful  performance  of  these  blocks  and  for  reducing  the  complications  have  been 
described. 
     The  technique chosen  in  this  study  was  the  Nerve  locator  assisted  subclavian 
perivascular technique.  In 1964 subclavian perivascular  technique was described by Winnie1 
and it allowed accurate percutaneous localisation of the plexus.  He used the concept that there 
is a constant relationship between the anterior and middle scalene muscles, the plexus and the 
first rib and that there is an advantage of the continuity of the neurovascular sheath of the 
brachial plexus.  Winnie’s concept that the roots of the plexus were sandwiched between the 
two scalene muscles and the muscles are always found to be inserted in the 1st rib.  Hence he 
introduced the needle between the two muscles and in the direction of the space between them. 
Thus by using a single needle technique eliciting paraesthesia or vascular pulsation as a guide 
to confirm the needle placement in the space he injected the anaesthetic solution, which will be 
confined to the perineural and perivascular area.  Hence he was almost certain of a complete 
and safe block.  This technique by Winnie was anatomically precise and conceptually logical.
          Elicitation of paraesthesia to confirm the needle position in nerve blocks are now 
becoming  less  popular  as  it  has  problems  in  the  form  of  direct  neuronal  damage  by  the 
advancing needle, patient discomfort and failure rates. While using nerve locator as an aid to 
the nerve blocks, these problems can be avoided.Various studies demonstrated its effective 
usefulness in peripheral nerve blocks 8,9,10,11,12.
            Bupivacaine hydrochloride was the first local anaesthetic that combined the properties 
of an acceptable onset, long duration of action and profound conduction blockade.
             Various agents like epinephrine, opioids, Ketamine, potassium chloride, verapamil 
neostigmine,  hyaluronidase and Sodium bicarbonate  have been used as  adjuvants   to  local 
anaesthetics in brachial plexus block to quicken the onset, increase the duration and enhance 
the quality of block and also to reduce the post operative analgesic requirements.  The results 
have been mixed and at times associated with side effects.  
          Clonidine as an additive to local anaesthetics has been studied in the intrathecal, epidural 
& caudal routes 4,5,6,7,.  It has been proved in these studies hat clonidine is as useful additive by 
way of improved analgesia and with sedation.
             Even though clonidine used as an adjuvant in wide range of doses           (30-300μgs) 
with local anaesthetics  to demonstrate its effects in various studies, Bernard et al41 in their 
study clearly concluded that the best dose to use clinically is 60-100μg  to  limit  the α2 agonist 
side effects.  Hence 100µg dose was chosen   in   this study.
          In this prospective randomised comparative study, 40 patients satisfying the selection 
criteria underwent brachial plexus block with or without addition of clonidine.  Comparison of 
onset,  completion,  duration  & intensity  of  blockade,  sedation,  haemodynamic  changes  and 
quality of analgesia between the two groups were observed and statistically analysed.  
           The onset of sensory and motor blockade was quicker in the clonidine group.  This 
could be due to the synergistic action of clonidine with that of local anaesthetics.
               The onset of motor block was found to be faster than the sensory block.  This may be 
attributed to the arrangement of nerve fibres in the trunks as described by Winnie40.  Motor 
fibres are located more peripherally than sensory fibres. Hence a local anaesthetic drug will 
begin to block motor fibers before it arrives at the centrally located sensory fibres.
                       Duration of sensory block tended to last longer than motor block in the present 
study.  This is in line with the observations made by de Jong et al33 who explained that larger 
fibres require a higher concentration of local anaesthetic than smaller fibres.   The minimal 
effective concentration of local anaesthetic for large (motor) fibers is greater than for small 
(sensory) fibers.  Thus, motor function return before pain perception and duration of motor 
block is shorter than the sensory block.
           Time taken to complete the motor&sensory blockade was significantly lesser in 
Clonidine group. 
           In this study, during postoperative period  pain scores were significantly lower in 
patients  who received  clonidine  in  addition  to  Bupivacaine.   The  number  of  patients  who 
required rescue analgesia was also lower in this group.
            As an α2-specific adrenergic agonist, it has been presumed that the block-prolonging 
effect of clonidine results from a pharmacodynamically mediated mechanism. Clonidine blocks 
the  conduction of C and A gamma fibres  and increases  potassium conductance in  isolated 
neurons and intensifies conduction block of local anaesthetics. However, the data supporting 
this  assumption is  conflicting.  For  example,  consistent  with the  presumption that  clonidine 
exerts  its  effects  pharmacodynamically,  several  studies  have  shown  that  peak  plasma 
concentrations of local anaesthetics are unaltered when clonidine is added.50,54 However, data 
from other  studies  have shown that  clonidine  does  decrease  peak local  anaesthetic  plasma 
concentrations  to  the  same  extent  as  epinephrine,  a  fact  that  supports  a  pharmacokinetic 
mechanism.18,52,53  Other  evidence  of  a  pharmacokinetic  mechanism  comes  from  studies 
showing that  clonidine  itself  (as  a  sole agent)is  incapable of  producing nerve block in  the 
absence of coadministered local anaesthetics. 49
            Sedation scores were higher in patients in clonidine group compared to control group 
during the intraoperative period. Even though sedation is  one of the side effects of clonidine, it 
is  a  desirable  one  for  the  surgical  procedure  during  intraoperative  period.  No  patient 
experienced airway compromise or required airway assistance due to this sedation. Heart rate 
in  clonidine group was significantly decreased during the intraoperative period. Both these 
effects  could be  due to  partial  vascular  uptake of  the  drug  and its  transport  to  the  central 
nervous system where it acts48. At the same time no haemodynamic instability was observed in 
both the groups.
             No complications with regard to the technique or drug was observed except accidental 
arterial puncture in one and decrease in heart rate (<50) in one of the cases.
SUMMARY
1. Onset time for both motor and sensory block was quicker in the     
           Bupivacaine with clonidine group.
2. Time taken for completion of both motor and sensory blockade was 
           significantly lesser in clonidine group.
3. There was no difference between the groups in the intensity of blockade.
4. The mean duration of both sensory & motor blockade was significantly 
           prolonged in clonidine group.
5. Sedation  was  statistically  significant  with  Bupivacaine-clonidine   group   in   the 
intraoperative period.
6. Heart rate significantly decreased in clonidine group during intraoperative  period.
7. There was no haemodynamic instability in both the groups in the study period.
8. There was no complication due to the addition of 100µg clonidine to 
           Bupivacaine.
     
CONCLUSION
                    In conclusion, clonidine 100µg (in 2ml)when used as an additive to 0.375% 
Bupivacaine(30ml) solution for Supraclavicular brachial plexus block, quickens the onset of 
sensory & motor blockade and prolongs the duration of sensory & motor blockade. It  also 
improves  the  quality  of  post  operative  analgesia  with  mild  intraoperative  sedation  and 
decreases  the  heart  rate  without  any  haemodynamic  instability.   Hence,  clonidine  can  be 
considered as a safe additive to local anaesthetic solution for brachial plexus blocks. 
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1.  PROFORMA
Name:                           Patient ID:                            Age/Sex:                  Wt:               ASA Status:
IP No:                                      Surgery:                   Duration of Surgery:                       Group :  B / BC               
Onset of block              - Motor :                          Sensory :
Completion of block    -  Motor :                          Sensory :
Intensity of block         -  Motor :                          Sensory :
Duration of block         -  Motor :                          Sensory : 
Sedation Score:                                                     Complication :
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